fda semaglutide warning news october 2025 The has officially approved the first GLP1 agonist pill specifically for weight loss., What to know?, ✅ It’s semaglutide, the same drug that is in Ozempic and Wegovy, ✅ It already exists in pill Ozempic and Wegovy are no

It's best to throw it away and use a new pen to make sure you're getting the full benefit of your medication

The STEP UP programme examined weight loss results among participants who took the 2.4 mg per week dose and those who took the 7.2 mg per week dose over a 72-week period

Furthermore, they were people already taking these diabetes medications, and researchers tracked outcomes over time

Semaglutide and the other GLP-1 agonists have the added benefit of central effects on the hunger centres in the hypothalamus as well as delaying gastric emptying to increase fullness and suppress appetite, a valuable tool for both the treatment of diabetes and weight loss management, but a potential risk for the use of sedation/anaesthesia

Drawing 40 units from a 10 mg/mL vial gives you nearly double the maximum recommended dose